» Articles » PMID: 35287619

Bilateral Paralysis of Peroneal Nerve After COVID-19 Disease: a Case Report

Overview
Journal BMC Neurol
Publisher Biomed Central
Specialty Neurology
Date 2022 Mar 15
PMID 35287619
Authors
Affiliations
Soon will be listed here.
Abstract

Background: COVID-19, caused by a novel coronavirus SARS-CoV 2 has rapidly developed into pandemic. This infectious disease affecting mainly respiratory system may cause multiple systemic disorders. With increasing number of new infected patients there are more and more cases with neurological complications secondary to COVID-19.

Case Presentation: Here we present a case of 67-years old Polish male with previously no comorbidities, who has developed bilateral paralysis of peroneal nerve after SARS-CoV 2 infection. Prior to the hospitalization he presented cough and fever and weakness. RT-PCR was reported positive for COVID-19 infection. Then he developed pneumonia and respiratory failure with bilateral lung consolidations on radiological examination. Laboratory findings revealed elevated levels of D-dimer, CRP, AspAT, GGTP, PCT and serum glucose. After discharge from hospital he was diagnosed with thrombophlebitis and prediabetes on follow-up visits. Due to problems with walking, numbness of toes and involuntary muscle spasms in hands, the patient went to the Neurological Outpatient Clinic. After neurological examination bilateral paralysis of peroneal nerve was revealed.

Conclusions: In this report we want to highlight one of the unexpected presentations of SARS-CoV 2 infection and emphasize the importance of neurological examination in COVID-19 patients.

Citing Articles

Post-COVID-19 Neurological Sequelae of Polyneuropathy and Encephalitis: A Comprehensive Case Report.

Manuel S, Sapone J, Lin F, Chalunkal M Cureus. 2024; 16(3):e56645.

PMID: 38646272 PMC: 11032167. DOI: 10.7759/cureus.56645.


Neuromuscular Disorders Associated With COVID-19.

Morgan L, Hollist M, Au K, Ayari L, Betts C, Kirmani B Neurosci Insights. 2023; 18:26331055231176251.

PMID: 37255741 PMC: 10225906. DOI: 10.1177/26331055231176251.

References
1.
Inciardi R, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D . Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):819-824. PMC: 7364333. DOI: 10.1001/jamacardio.2020.1096. View

2.
Asadi-Pooya A, Simani L, Shahisavandi M, Barzegar Z . COVID-19, de novo seizures, and epilepsy: a systematic review. Neurol Sci. 2020; 42(2):415-431. PMC: 7686454. DOI: 10.1007/s10072-020-04932-2. View

3.
Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A . Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020; 277(8):2251-2261. PMC: 7134551. DOI: 10.1007/s00405-020-05965-1. View

4.
Martelletti P, Bentivegna E, Spuntarelli V, Luciani M . Long-COVID Headache. SN Compr Clin Med. 2021; 3(8):1704-1706. PMC: 8136258. DOI: 10.1007/s42399-021-00964-7. View

5.
Paliwal V, Garg R, Gupta A, Tejan N . Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020; 41(11):3039-3056. PMC: 7491599. DOI: 10.1007/s10072-020-04708-8. View